Giuseppe Gullo - Concepedia

Author

Giuseppe Gullo

St. Vincent's University Hospital ORCID

Also Known As

Barbara Menzaghi, G Gullo, G. Giuseppe, G. Gullo, Garofano Giuseppe, Giuseppe Gullo, Gullo Giuseppe, Laura Comi

Publications

999

Citations

H-Index

Concepts

All Affiliations

St. Vincent's University Hospital Dublin City University University Hospital Galway St. James's Hospital University College Dublin

About

Giuseppe Gullo is an author at St. Vincent's University Hospital specializing in medicine, oncology, and breast cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	172
2	Natural Sciences	1	1	19
3	Biochemistry	1	1	19
4	Cell Biology	1	1	10
5	Immunology	1	1	22

Giuseppe Gullo

Publications

513

Citations

H-Index

Page 1

	Year	Citations
Expression of multidrug resistance markers ABCB1 (MDR-1/P-gp) and ABCC1 (MRP-1) in renal cell carcinoma Naomi Walsh, Annemarie Larkin, Susan Kennedy, BMC Urology	2009	90
MDR1/P-glycoprotein and MRP-1 drug efflux pumps in pancreatic carcinoma. Lorraine O’Driscoll, Naomi Walsh, A. Larkin, PubMed	2007	61
First evidence of a therapeutic effect of miransertib in a teenager with Proteus syndrome and ovarian carcinoma Chiara Leoni, Giuseppe Gullo, Nicoletta Resta, American Journal of Medical Genetics Part A	2019	48
Uveal Melanoma in Ireland Caroline Baily, Valerie O’Neill, Mary Dunne, Ocular Oncology and Pathology	2018	37
HER-targeted tyrosine kinase inhibitors enhance response to trastuzumab and pertuzumab in HER2-positive breast cancer Alexandra Canonici, Laura Ivers, Neil T. Conlon, Investigational New Drugs Breast OncologyOncologyMedicineReceptor Tyrosine KinaseImmune Checkpoint Inhibitor	2018	29
Reversible Posterior Leukoencephalopathy Syndrome and Bevacizumab in Breast Cancer Francesco Sclafani, Giuseppe Gullo, Janusz Mezynksi, Journal of Clinical Oncology Breast OncologyMedicinePathologyBreast CancerOncology	2012	27
Late cardiac effects of chemotherapy in breast cancer survivors treated with adjuvant doxorubicin: 10-year follow-up Gillian Murtagh, Tomás G. Lyons, Eoin O’Connell, Breast Cancer Research and Treatment Cardiovascular ToxicityBreast OncologyMedicinePharmacologyBreast Cancer Survivors	2016	26
Transferrin-bound proteins as potential biomarkers for advanced breast cancer patients Paul Dowling, Valentina Palmerini, Michael Henry, BBA Clinical	2014	22
Level of HER2/neu gene amplification as a predictive factor of response to trastuzumab-based therapy in patients with HER2-positive metastatic breast cancer Giuseppe Gullo, Daniela Bettio, Valter Torri, Investigational New Drugs Cox ModelBreast OncologyPredictive FactorMedicineImmunology	2008	22
Metabolomic and proteomic analysis of breast cancer patient samples suggests that glutamate and 12-HETE in combination with CA15-3 may be useful biomarkers reflecting tumour burden Paul Dowling, Michael Henry, Paula Meleady, Metabolomics BiochemistryMedicineNatural SciencesBiomarker TargetPharmacology	2014	19

Page 1